Clinical evaluation of the implementation of the first pilot Russian integrated program for an integrated approach to the management of diabetes mellitus “NORMA”

BACKGROUND: Despite progress in the treatment of patients with diabetes mellitus (DM), the problem of achieving target values of glycemic control remains relevant. In this regard, the search for new integrated solutions that could strengthen disease control and improve clinical outcomes becomes relevant.

AIM: To assess the impact of the developed integrated approach to disease management on the clinical and metabolic outcomes of patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) participating in the “NORMA” pilot program for 3 and 6 months.

MATERIALS AND METHODS: “NORMA” is the first Russian program designed to implement an integrated approach to DM management combines structured online education, blood glucose monitoring, supervision by endocrinologist, and administrative support. Interium retrospective analysis analysis of pre-existing data generated in the Program was performed from October 2020 to November 2021. Adults (≥18 years) with uncontrolled T1DM or T2DM on insulin (HbA_1c>7,0%) with duration of DM ≥6 months were included. The following characteristics were considered: social-demographic parameters, duration of DM, complications, HbA_1c, hypoglycemia events, daily insulin dose, patients’ perception of DM checklist (scaled 1-10), level of DM knowledge (questionnaire of 20 points).

RESULTS: Data from 185 persons were analyzed: 132 with T1DM and 53 with T2DM, 67% women, the mean age was 41.3±14.4 years; the median DM duration was 12.0 [6.0; 19.0] years, 30 persons (16.3%) were free of any DM complications. Mean HbA_1c decreased from 8.8±1.5% to 7.4±1.2% at month 3, and to 7.6±1.5% at month 6 (p<0.001). HbA_1c <7.0% was achieved in 38.9% and 38.1% participants after 3 and 6 months, respectively. The total insulin dose has not changed within the program. The DM knowledge level after 3 months of Program increased significantly by 25.4±15.0% (p<0.001). The mean scores of patients’ perceptions of DM after 3 and 6 months increased by 2.1±10.2 % and 2.4±11.0 % (p<0.01), but the median scores (interquartile range) did not change: 0.00% (-3.00–6.00%) and 0.50% (-3.00–9.00%) respectively.

CONCLUSION: In a real-life setting, the implementation of an integrated approach to the diabetes management was associated with the improvement of glycemic control without significant changes of total insulin dose.

1. Tieken K, Paramasivan AM, Goldner W, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986. doi: https://doi.org/10.1056/NEJM199309303291401

2. Tieken K, Paramasivan AM, Goldner W, et al. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes — 2022. Diabetes Care. 2022;45(S1):S8-S16. doi: https://doi.org/10.2337/dc22-S001

3. Gubitosi-Klug RA. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions. Diabetes Care. 2014;37(1):44-49. doi: https://doi.org/10.2337/dc13-2148

4. Hawkes CP, Willi SM, Murphy KM. A structured 1‐year education program for children with newly diagnosed type 1 diabetes improves early glycemic control. Pediatr Diabetes. 2019;20(4):460-467. doi: https://doi.org/10.1111/pedi.12849

5. Kisokanth G, Jegarajah I, Shamini P, et al. A preliminary study on diabetes self-management education and glycemic control among patients with diabetes mellitus. J Nurs Educ Prac. 2019;9(9):98-103. doi: https://doi.org/10.5430/jnep.v9n9p98

6. Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Diabetes Mellitus. 2021;24(S1):1-235 (In Russ.). doi: https://doi.org/10.14341/DM12802

7. Dedov II, Shestakova MV, Vikulova OK, et al. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes mellitus. 2021;24(3):204-221. (In Russ.). doi: https://doi.org/10.14341/DM12759

8. Charpentier G, Benhamou P-Y, Dardari D, et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves hba1c in poorly controlled type 1 diabetic patients. Diabetes Care. 2011;34(3):533-539. doi: https://doi.org/10.2337/dc10-1259

9. Franc S, Borot S, Ronsin O, et al. Telemedicine and type 1 diabetes: Is technology per se sufficient to improve glycaemic control? Diabetes Metab. 2014;40(1):61-66. doi: https://doi.org/10.1016/j.diabet.2013.09.001

10. Daoudi A, Joubert M, Franc S, et al. A Smartphone for adjustment of basal insulin dose and for coaching: Benefits in terms of glycaemic control for type 2 diabetes patients. Diabetologia. 2013;(56):S426

11. Hsu WC, Lau KH, Huang R, et al. Utilization of a cloudbased diabetes management program for insulin initiation and titration enables collaborative decision making between healthcare providers and patients. Diabetes Technol Ther. 2016;18(2):59-67. doi: https://doi.org/10.1089/dia.2015.0160.

12. Bergenstal RM, Bashan E, McShane M, et al. Can a tool that automates insulin titration be a key to diabetes management? Diabetes Technol Ther. 2012;14(8):675-682. doi: https://doi.org/10.1089/dia.2011.0303

13. Davies M, Bain S, Charpentier G, et al. A randomized controlled, treat-to-target study evaluating the efficacy and safety of insulin glargine 300 U/mL (Gla-300) administered using either device-supported or routine titration in people with type 2 diabetes. J Diabetes Sci Technol. 2019;13(5):881-889. doi: https://doi.org/10.1177/1932296818821706

14. Шевченко О.Р., Колбин А.С. Прагматические клинические исследования // Качественная клиническая практика. — 2020. — Т. 13. — №3. — 52-60. [Shevchenko OR, Kolbin AS. Pragmatic clinical trials. Kachestvennaya Klin Prakt. 2020;13(3):52-60. (In Russ.)]. doi: https://doi.org/10.37489/2588-0519-2020-3-52-60

15. Ji H, Chen R, Huang Y, et al. Effect of simulation education and case management on glycemic control in type 2 diabetes. Diabetes Metab Res Rev. 2019;35(3):e3112. doi: https://doi.org/10.1002/dmrr.3112

16. von Storch K, Graaf E, Wunderlich M, et al. Telemedicine-assisted self-management program for type 2 diabetes patients. Diabetes Technol Ther. 2019;21(9):514-521. doi: https://doi.org/10.1089/dia.2019.0056